No. 1 Story
ACCC clears Optus to scrap HFC network and use NBN instead
The ACCC has cleared, provisionally, the proposed deal between Optus and NBN Co under which Optus is to be paid around $800m to shut down its HFC network and transfer customers onto the NBN. read moreMore From
Dysport approved by FDA for wrinkle treatment
William Atkins
Sunday, 03 May 2009 18:20
Page 1 of 2
The U.S. Food and Drug Administration (FDA) made the announcement on Saturday, May 2, 2009, that is had approved the branded name Dysport as a way to treat forehead wrinkles and frown lines.Dysport, previously called Reloxin, is made from the type A toxin called Clostridium botulinim. It works by relaxing the muscles that are causing the wrinkles and worry lines, what are also called glabellar lines.
According to the website of the drug’s maker Ipsen Biopharm, Dysport is scientifically called abobotulinumtoxinA.
This new wrinkle drug is made from the same active ingredient (C. botulinim) as Botox, made by Allergan, which has been in the news lately, too.
In the iTWire article FDA to strengthen warnings on Botox type drugs, the FDA is requiring stronger warning labels on all drugs made with C. botulinim because of the possibilities of breathing and swallowing problems, along with rare reported cases of hospitalization and death.
When C. botulinim is injected into a wrinkle the toxin interferes with (the release of acetylcholine within the neuromuscular junction of) nerve impulses within the muscles, and, thus, causes paralysis of those local muscles.
The muscles are then unable to contract for several months.
Page two concludes.
You think you have a disaster recovery plan?
Think again. Most businesses only have PART of a DR plan - and this spells business disaster in the event of an IT disaster.
Download The Seven Sins of Disaster Recovery White Paper now and find out how you can prevent this happening to you.
